David David Pittman from medpagetoday.com has written an article on FDA’s push to include sicker patients in clinical trials. In the article David brings up the new internal memo that requests drug reviewers to push for a broader population in trials. By doing this it...
Cameron from Total Biopharma introduces an interesting artical about how clinical trials are being designed and executed to fit the changing needs of the industry. With costs and complexity increasing in clinical reseach, Total Biopharma offers their own A-Z...
Centerwatch.com produced an interesting article on the implementation of new strategies to improve drug developer’s access to comparator drugs for clinical testing. The article brings to light the difficulty of obtaining comparator drugs, with the Tufts Center for...
Yevgeniy Feyman of Forbes has written an intriguing article entitled “Shocking Secrets of FDA Clinical Trials Revealed” the costs of bringing a new drug to market. Feyman shares that “according to Joseph Dimasi of the Tufts Center for the Study of Drug Development,...
With China’s economy continuing to develop many people in their population will begin to receive advanced healthcare for the first time. Now it’s time to look to see how China can learn from the healthcare insurance systems from around the world and what opportunities...
